SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) today announced that it has been added to the newly formed NASDAQ NeuroInsights Neurotech Index, launched September 25, 2007. The Nasdaq Stock Market Inc. (NDAQ) and NeuroInsights, a research firm that focuses on neurotechnology, partnered to create the index, which is disseminated under the symbol “NERV.”
